With the MiniMed™ 670G system helping Nicky stay in range∆, every waking moment is a new opportunity to spend quality time with her family and friends. Now she can fully enjoy horseback riding, soccer and sleepovers — all the things that help make her an active, confident teenager.
Nikhita and her sister researched technology options available to manage her diabetes. When they discovered that the MiniMed™ 670G system with SmartGuard™ technology automatically¶, ∆ adjusts insulin to help keep glucose levels in range 24 hours a day, they knew it was the right fit.
With new information to optimize his glucose levels when he travels for work, John has become the confident traveler he always wanted to be. His wife sleeps better now, knowing that his glucose levels are stabilized automatically∆ with SmartGuard™ technology.
The MiniMed™ 670G system with SmartGuard™ technology automatically∆ helps keep both Joanne and her son in range, day and night. Joanne isn’t as worried about long-term complications from diabetes anymore, and she sees a bright future for her son.
With his glucose in range no matter where he is, Ryan’s getting his first true taste of independence. His mom feels comfortable letting him travel with his hockey team and Ryan can enjoy life as a teenager even more.
The MiniMed™ 670G system offers SmartGuard™, the only technology that mimics some of the functions of a healthy pancreas by providing two new levels of automated insulin delivery.
SUSPEND BEFORE LOW§
Sleeping soundly. Waking up energized.
The MiniMed™ 670G system lets you wake up every morning well-rested and ready to take on the day.
Living life more spontaneously.
Instead of injecting insulin many times a day, the MiniMed™ 670G system helps keep your sugar levels safely in range based on how you live every day.*,#
Enjoying meals without interruption.
Instead of figuring out complex insulin doses on your own, simply check your glucose and enter the number of carbs when you give a mealtime bolus. The MiniMed™ 670G system assists with the rest, automatically∆ adjusting insulin while you enjoy your meal without interruption.*,#
Having more time for family and friends.
Now you can spend less time worrying and more time bonding with family and friends. To help you stay in range, the MiniMed™ 670G system delivers insulin based on your sugar levels 24 hours a day with minimal input and periodic sensor calibration.*,#
|Water Resistance||Waterproof pump, protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.|
|Sizing||The pump dimensions in inches are approximately 2.1 width x 3.78 length x 0.96 depth. The weight of the pump is approximately 3 ounces.|
|Environmental Conditions||The MiniMed 670G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump storage temperature range is from -4 °F (-20 °C) to 122 °F (50 °C). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi)|
|Pump Memory||At any time the user can review 90 days of pump history|
|Compatible Infusion Sets||Medtronic Diabetes provides a variety of infusion sets to fit your needs.|
|Guardian Link 3 Transmitter||Used with your pump for Continuous Glucose Monitoring (CGM). A device that connects to a glucose sensor. The transmitter collects data measured by the sensor and wirelessly sends this data to monitoring devices.|
|Bolus Speed Options||
|Bolus Programming Increments||
|Basal Delivery Rate Range||0 to 35 units per hour or the Max Basal Rate amount, whichever is lower.|
|Guardian Sensor 3||Used with your pump for CGM. The sensor is a small part of the continuous glucose monitoring system that you insert just below your skin to measure glucose levels in your interstitial fluid.|
|CareLink™ USB||Used to upload system data to the diabetes management software using a USB port on your computer.|
|One-press Serter||The serter is used as an aid for inserting the sensor. It is indicated for single-patient use and is not intended for multiple patient use.|
|Battery & Power||The pump requires one new AA (1.5 V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery.|
|Reservoir||Medtronic reservoir MMT-332A, 3.0 ml (300-unit)|
|CONTOUR® NEXT LINK 2.4 Glucose Meter||The MiniMed 670G system comes with a compatible meter. It wirelessly connects to your pump, allowing you to send BG meter readings to your pump.|
BELTS AND POUCHES
Soft belts and pouches can be sized for the perfect fit and give you a comfortable way to keep your pump close and concealed. They can be worn on different parts of your body — the waist, leg, thigh or arm — discreetly under clothing.
CASES AND CLIPS
With our selection of cases and clips, there are many ways to wear your insulin pump. You can attach your pump to your waistband or belt, protect it in your pocket, or even clip it under clothing.
If you've been considering a change, this could be a great time to make the move to our latest technology. To learn more about your eligibility and potential out-of-pocket costs, call the number below and we’ll help get you started with a free insurance coverage check.
or complete the form and a Diabetes Therapy Consultant will get in touch.
Click here for assistance if your insurance does not currently cover the MiniMed 670G system.
“A life-changing breakthrough.”
“This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,”
“Automated insulin delivery system will ease some of the burden of living with the condition”
One of "the 25 best inventions of 2016”
“We applaud the @US_FDA's approval of the first hybrid insulin delivery system.”
“It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.”
“A groundbreaking new device could change the lives of millions of people living with diabetes.”
Meet the MiniMed Ambassadors.
MiniMed Ambassadors are people living with diabetes and using Medtronic products. They’re available to have honest one-to-one conversations with you or your loved ones about their experiences.
If you have questions regarding the MiniMed™ 670G system and how it may fit into your daily life, an Ambassador is just an email away and ready to answer your questions.
Training & Education
We offer personal training, tailored to help you get the most from your MiniMed™ 670G system. Count on expert support from diabetes educators, therapy consultants and clinical specialists.
Our helpline team is here for you around the clock to answer all your questions. Our unmatched service is the #1 reason customers stay with us.
Our free coaching program helps you get started. Your StartRightSM representative prepares you for upcoming product training, setting diabetes therapy goals and tracking progress.
When you travel with your MiniMed 670G system, get access to our global support network. We’ve got you covered in more than 100 countries worldwide.
* Mean Absolute Relative Difference.
** 3-4 calibrations per day required.
¶ Some user interaction required.
# Based on sensor glucose. ∆ Refers to AutoMode. Some interaction required. Individual results may vary.
† The pump is protected against the effects of continuous immersion in up to 12 feet (3.6 meters) of water for up to 24 hours at a time at the time of manufacture. This is classified as IPX8 rating. See user guide for more details.
∆ Indicated for type 1 patients 14 years of age or older.
§ WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia..
‡ WARNING: Do not use Auto Mode for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in Auto Mode. Therefore, Auto Mode could deliver too much insulin. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection of insulin before you resume Auto Mode.
1. Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR®NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria.
Important Safety Information: MiniMed™ 670G System
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.
WARNING: Medtronic performed an evaluation of the MiniMed 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.
Only use rapid acting U100 insulin with this system. Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details, including product and important safety information concerning the system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library.
Important Safety Information: MiniMed™ 630G System with SmartGuard™ technology
The MiniMed™ 630G system with SmartGuard™ technology requires a prescription. It is intended for continuous delivery of basal insulin and administration of insulin boluses for the management of diabetes mellitus in persons 16 years of age or older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The SmartGuard feature allows one to program the pump to temporarily suspend delivery of insulin for up to two hours when the sensor glucose value falls below a predefined threshold value. The MiniMed™ 630G system is not intended to be used directly for making therapy adjustments or preventing or treating hypoglycemia. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare professional. The information provided by CGM systems is intended to supplement, not replace, blood glucose information obtained using a blood glucose meter (BGM). A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 Meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. Do not calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always’ send mode. Pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day, or who are unwilling or unable to maintain contact with their healthcare professional, or whose vision or hearing does not allow recognition of pump signals and alarms. Insulin pumps use U100 rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately.
WARNING: The SmartGuard Suspend on low feature will cause the pump to temporarily suspend insulin delivery for two hours when the sensor glucose reaches a set limit. Under some conditions of use the pump can suspend again resulting in very limited insulin delivery. Prolonged suspension can increase the risk of serious hyperglycemia, ketosis, and ketoacidosis. Before using the SmartGuard Suspend on low feature, it is important to read the SmartGuard Suspend on low information in the Getting Started Guide and the MiniMed™ 630G System User Guide and discuss proper use of the SmartGuard Suspend on low feature with your healthcare professional.
Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected.
For complete details, including product and important safety information concerning the system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library.
MiniMed is a registered trademark and SmartGuard is a trademark of Medtronic, MiniMed Inc.
Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.